* BIOLASE Inc BIOL.OQ reported a quarterly adjusted loss of 6
cents per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss of 5
cents per share.
* Revenue rose 69.7% to $8.12 million from a year ago; analysts
expected $7.79 million.
* BIOLASE Inc's reported EPS for the quarter was a loss of 6
cents.
* The mean earnings estimate of analysts had fallen by
about 36.4% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* BIOLASE Inc shares had fallen by 31.2% this quarter and
gained 39.2% so far this year.
* The company reported a quarterly loss of $7.43 million.
* Wall Street's median 12-month price target for BIOLASE Inc is
$2.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated May 14 at 07:29 a.m. GMT.
All figures in US dollars